LOW-VOLUME · HOSP-MID
ertugliflozin Side Effects
ertugliflozin (also sold as Steglatro) is a LOW-VOLUME FAERS extract #488 of 524 by FAERS report count. Still opens on HOSP-MID: 28.0% mention hospitalization (290 reports).
Data updated 2026-05-15
- 1,037
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
ertugliflozin: 28.0% mention hospitalization (290 reports). Death stamp DEATH-MARKED; volume band LOW-VOLUME #488 of 524 by FAERS report count.
Thinner FAERS extract for ertugliflozin (Steglatro) (1,037 reports #488 of 524 by FAERS report count). 28.0% mention hospitalization (290 reports). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2013–2025). Stamps SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
NAUSEA leads 86 of 1,037 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (271 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death appears on 12 reports (1.2% - MARKED). Reactions below co-occur in those rows only.
| Reaction | Reports |
|---|---|
| DEATH | 4 |
| OEDEMA PERIPHERAL | 3 |
| SEPSIS | 3 |
| BLOOD ALBUMIN DECREASED | 2 |
| BLOOD ALKALINE PHOSPHATASE INCREASED | 2 |
| BLOOD CALCIUM DECREASED | 2 |
| BLOOD CREATININE DECREASED | 2 |
| C-REACTIVE PROTEIN ABNORMAL | 2 |
| CARDIAC ARREST | 2 |
| CHOLELITHIASIS | 2 |
| ENTEROCOCCAL INFECTION | 2 |
| GAMMA-GLUTAMYLTRANSFERASE INCREASED | 2 |
| HEPARIN-INDUCED THROMBOCYTOPENIA | 2 |
| HYPERGLYCAEMIA | 2 |
| ORGAN FAILURE | 2 |
| PANCREATIC DUCT OBSTRUCTION | 2 |
| PANCREATITIS NECROTISING | 2 |
| PROTEIN TOTAL DECREASED | 2 |
| PULMONARY EMBOLISM | 2 |
| WOUND NECROSIS | 2 |
Reactions in Hospitalization Reports
Hospitalization mid-share (290, 28.0%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| DIABETIC KETOACIDOSIS | 45 |
| VOMITING | 25 |
| NAUSEA | 24 |
| URINARY TRACT INFECTION | 20 |
| DECREASED APPETITE | 18 |
| DIARRHOEA | 14 |
| DIZZINESS | 14 |
| FOURNIER^S GANGRENE | 14 |
| BRASH SYNDROME | 13 |
| EUGLYCAEMIC DIABETIC KETOACIDOSIS | 13 |
| PNEUMONIA | 12 |
| ABDOMINAL PAIN | 10 |
| ACUTE KIDNEY INJURY | 10 |
| DIABETES MELLITUS | 10 |
| ASTHENIA | 9 |
| IMPAIRED GASTRIC EMPTYING | 9 |
| KETOACIDOSIS | 9 |
| CONSTIPATION | 8 |
| DIABETES MELLITUS INADEQUATE CONTROL | 8 |
How to read ertugliflozin FAERS figures (SIGNAL · DEATH-MARKED · HOSP-MID)
FAERS holds 1,037 voluntary reports linked to ertugliflozin (Steglatro), 2013-2025. Death is listed on 12 (1.2%). Hospitalization appears on 290 (28.0%). Top co-reported indication: Type 2 Diabetes Mellitus.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with ertugliflozin
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-MARKED · HOSP-MID stamps.
ABS(total_reports) peer at 1,076 FAERS cases (Δ 39 heavier vs ertugliflozin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 952 FAERS cases (Δ 85 lighter vs ertugliflozin); DEATH-MARKED · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 1,132 FAERS cases (Δ 95 heavier vs ertugliflozin); DEATH-MARKED · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 923 FAERS cases (Δ 114 lighter vs ertugliflozin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 61.0 pp vs ertugliflozin's DEATH-MARKED): CASELOAD · HOSP-MID.
ertugliflozin stamps SIGNAL · SEX-BALANCED; class peers and methodology beat restating the same FAERS caveats on every effects URL.